Naugler et al. have previously shown that estrogen effectively suppressed IL-6 expression in female mice via MYD88/NF-κB signaling, and thereby reduced liver damages and HCC multiplicity48. This evidence concerns the gene IL6 and hepatocellular carcinoma.